Table 2 Summary Statistics of Un-Matched Variables and Outcomes for the 684 Consolidated Recommendations
Variable | Accepted (N = 519) | Rejected (N = 165) | P-value |
|---|---|---|---|
Demographic Factors | |||
Phase of CPIa | Phase II: 271 (52%) | Phase II: 64 (39%) | 0.003 |
Total Number of CPI | 2 (1–38) | 3 (1–38) | < 0.001 |
Risk of Hospitalization Factors | |||
Poly-pharmacy | Yes: 80 (15%) | Yes: 40 (24%) | 0.009 |
Multi-comorbidities | Yes: 131 (25%) | Yes: 59 (36%) | 0.009 |
Vascular Disease | Yes: 39 (8%) | Yes: 22 (13%) | 0.022 |
ACEI/ARB | Yes: 48 (9%) | Yes: 25 (15%) | 0.032 |
Diuretic | Yes: 42 (8%) | Yes: 22 (13%) | 0.044 |
Renal Disease | Yes: 90 (17%) | Yes: 44 (27%) | 0.009 |
Liver Disease | Yes: 14 (3%) | Yes: 11 (7%) | 0.018 |
High Alert Medication | Yes: 189 (36%) | Yes: 76 (46%) | 0.027 |
Clinical Pharmacy Recommendation Types | |||
Drug Prescribing | Yes: 326 (63%) | Yes: 129 (78%) | < 0.001 |
Efficacy Related | Yes: 180 (35%) | Yes: 83 (50%) | < 0.001 |
Stop a Medication | Yes: 137 (26%) | Yes: 69 (42%) | < 0.001 |
Add a Medication | Yes: 108 (21%) | Yes: 48 (29%) | 0.027 |
Scores | |||
Consultancy | 0.0 (0.0–1.0) | 0.0 (0.0–1.0) | 0.029 |
Rejection | 0.0 (0.0–0.8) | 0.5 (0.0–1.0) | < 0.001 |
Combined CP Success | 0.9 (0.6–1.0) | 0.9 (0.6–1.0) | < 0.001 |
Physician Rejection | 0.2 (0.0–0.8) | 0.2 (0.0–1.0) | < 0.001 |
Outcomes | |||
Hospital Stay, Total | 3.0 (0.5–59.0) | 4.0 (0.5–32.0) | 0.066 |
ICU Stay, Total | 0.0 (0.0–59.0) | 0.0 (0.0–17.0) | 0.412 |
Hospital Stay, After Index | 1.0 (0.0–43.0) | 2.0 (0.0–30.0) | 0.232 |
ICUa Stay, After Index | 0.0 (0.0–43.0) | 0.0 (0.0–16.0) | 0.119 |
Readmission | Yes: 80 (15%) | Yes: 27 (16%) | 0.770 |
Mortality | Died: 8 (2%) | Died: 5 (3%) | 0.222 |
Cost of Hospitalization (JDa) | 1149 (94–23,686) | 1388 (200–22,823) | 0.005 |